CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- 4 Gift CEO, Pres., CFO Treas & Secty gave 20,000 shares (gift)
- 3/A Insider 3/A
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
Page 9 of 13 · 259 filings